Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma

Prior treatment

• Suffering from severe diabetic retinopathy, retinal detachment, central retinal vein or artery occlusion, retinal chromosomal degeneration, macular degeneration, macular edema, and determined by researchers to potentially affect surgical safety;
• Having clinically significant corneal dystrophy, active inflammation or having undergone surgery that may interfere with the reliability of intraocular pressure measurement;

Other illness

• Patients with traumatic, malignant uveitis, neovascular or glaucoma related to vascular diseases;
• Patients with retrobulbar tumors, thyroid eye disease, cavernous sinus fistula, Sturge-Weber syndrome or any other disease that may cause elevated venous pressure in the outer sclera;
• Suffering from eye or systemic diseases that affect surgical safety or subsequent examinations;
• Failure to follow the doctor's advice;

Age

• Pregnant women, lactating women, women of childbearing age who plan to get pregnant during the research period or are unable to take effective contraceptive measures;

Other

• Patients with angle-closure, pigmentary or pseudo-exfoliative glaucoma;
• Patients with identifiable congenital abnormalities of the anterior chamber Angle;
• Other circumstances where the researcher determines that the patient is not suitable for inclusion

• Gender is not limited. Applicants must be 18 years old or above;
• Study patients whose eyes were diagnosed with open-angle glaucoma;
• The study eye was diagnosed with cataract and met the conditions for phacoemulsification, with the best corrected visual acuity ≤0.7(patients with the best corrected visual acuity \>0.7 who were determined by the researcher to need cataract surgery could be enrolled);
• Angular endoscopy confirmed that the opening Angle of the study eye was normal (defined as Shaffer grade ≥3, and there was no peripheral anterior iris adhesion, polycythemia or other abnormal conditions that might affect the correct placement of the stent);
• The patient is capable and willing to provide written informed consent and participate in the regular postoperative follow-up as required.